| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.43 | 0.009 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |